Parnell Pharmaceuticals Holdings Cash on Hand 2014-2018 | PARNF
Parnell Pharmaceuticals Holdings cash on hand from 2014 to 2018. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Parnell Pharmaceuticals Holdings Annual Cash on Hand
(Millions of US $) |
| 2021 |
$3 |
| 2020 |
$3 |
| 2019 |
$3 |
| 2018 |
$3 |
| 2017 |
$2 |
| 2016 |
$5 |
| 2015 |
$4 |
| 2014 |
$14 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
Parnell Pharmaceuticals Holdings Quarterly Cash on Hand
(Millions of US $) |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$2 |
| 2016-12-31 |
$5 |
| 2016-09-30 |
$2 |
| 2015-12-31 |
$4 |
| 2015-09-30 |
|
| 2015-06-30 |
$14 |
| 2015-03-31 |
|
| 2014-12-31 |
$14 |
| 2014-09-30 |
|
| 2014-06-30 |
$19 |
| 2014-03-31 |
$4 |
| 2013-06-30 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
